An unsettling new study has found that children two years old and under who took asthma medication had stunted growth.
The study, which involved 12,000 children of two years of age and under who take asthma medicine, found that they are likely to be shorter in adulthood than they would be otherwise, according to a Mirror report.
The study centers around what are known as inhaled corticosteroids, which are drugs used in inhalers that are meant to treat breathing conditions. Often, they are prescribed to very young children who suffer from the condition.
However, the study is bad news for those children, as the data showed they were short for their age and those problems would probably continue into adulthood. Essentially, the research shows that there is a link between long-term treatment of ICS and stunted growth in children who would have otherwise been healthy, said lead researcher Dr. Antti Saari according to the report. The study was conducted by the University of Eastern Finland and Kuopia University Hospital.
Corticosteroids have helped many asthma sufferers live relatively normal lives. They are administered via inhalers, which are often carried on the person in case of asthma attacks. However, no one had conducted a large study on how they affect children until now, and the news is obviously not good.
However, doctors cautioned that the results of the study shouldn’t stop them from giving their children the medicine, as it may save their life, whereas the interference on bone growth is relatively minor and certainly not life-threatening, unlike an asthma attack.